Article Details

New Drug for Heart Failure on Path to Approval Analyst Says - Streetwise Reports

Retrieved on: 2022-06-20 14:10:03

Tags for this article:

Click the tags to see associated articles and topics

New Drug for Heart Failure on Path to Approval Analyst Says - Streetwise Reports. View article details on hiswai:

Excerpt

Omecamtiv mecarbil is the California-based biopharma's lead drug candidate, awaiting approval in heart failure. Whereas the PDUFA date delay is ...

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up